Cardiac Dimensions

Cardiac Dimensions is a medical technology company focused on improving treatment for people with heart failure, particularly those with functional mitral regurgitation (FMR). Its approach aims to address the underlying condition as well as related symptoms, with the goal of helping patients feel better and live longer.

The company’s featured product is the Carillon Mitral Contour System, a device-based therapy designed to work with the heart’s natural structure and function. It is delivered through a minimally invasive percutaneous procedure, typically lasting about an hour, and does not prevent patients from receiving other treatments if needed. Cardiac Dimensions reports that published European studies have found improvements in quality of life, mitral regurgitation, and left ventricular volume among many treated patients.

The company also supports clinical research, including the U.S. EMPOWER trial, which is enrolling heart failure patients with enlarged ventricles and FMR. Its website provides information for patients and physicians, study details, publications, news, and educational resources about the Carillon therapy and the evidence behind it.